Skip to main content

Table 3 MPR percentiles variation in the private sectors for both medicine types in Qatar and Lebanon

From: Relationship between pharmaceutical pricing strategies with price, availability, and affordability of cardiovascular disease medicines: surveys in Qatar and Lebanon

Country/sector

Medicine and product type

Median MPR

25th percentile

75th percentile

Qatar/ Other Sector

Acetylsalicylic acid- OB

12.07

11.91

12.07

Atorvastatin 20 mg- OB

24.11

24.11

24.11

Atorvastatin 20 mg- LPG

29.06

27.02

30.47

Lebanon/ Private Sector

Atorvastatin 20 mg- LPG

15.34

9.96

18.51

Hydrochlorothiazide 25 mg- OB

14.25

13.43

15.07

Captopril 50 mg- OB

3.83

3.66

3.83